Results 161 to 170 of about 132,104 (228)

MRD in Philadelphia Chromosome-Positive ALL: Methodologies and Clinical Implications. [PDF]

Curr Hematol Malig Rep
Tran V, Salafian K, Michaels K, Jones C, Reed D, Keng M, El Chaer F.   +6 more
europepmc   +1 more source

Efficacy and safety of olverembatinib as maintenance therapy after allogeneic hematopoietic cell transplantation in Philadelphia chromosome-positive acute lymphoblastic leukemia. [PDF]

Ann Hematol
Kong J, Zheng FM, Yan CH, Wang JZ, Fu HX, Wang ZD, Suo P, Hu GH, Lv M, Chen H, Mo XD, Xu LP, Zhang XH, Huang XJ, Wang Y.   +14 more
europepmc   +1 more source

How I treat Philadelphia chromosome-like acute lymphoblastic leukemia in children, adolescents, and young adults.

Blood
Tran TH, Tasian SK.
europepmc   +1 more source

Nilotinib Versus Imatinib in Philadelphia Chromosome-Positive Chronic Myeloid Leukemia (Ph+ CML): A Systematic Review and Meta-Analysis of Randomized Controlled Trials (RCTs). [PDF]

Cureus
Zafar F, Poombal F, Ashraf L, Shivakumar D, Wankhade D, Winayak R, Ali Malik GM, Mahapatra SS, G C S, Huynh T, Mylavarapu M.   +10 more
europepmc   +1 more source

Patient-reported outcomes in Philadelphia chromosome-positive acute lymphoblastic leukemia patients treated with ponatinib or imatinib: results from the PhALLCON trial. [PDF]

Leukemia
Ashaye A, Shi L, Aldoss I, Montesinos P, Vachhani P, Rocha V, Papayannidis C, Leonard JT, Baer MR, Ribera JM, McCloskey J, Wang J, Gao S, Rane D, Guo S.   +14 more
europepmc   +1 more source

Characterization of Asciminib-Resistant Philadelphia Chromosome-Positive Cells. [PDF]

World J Oncol
Okabe S, Moriyama M, Gotoh A.
europepmc   +1 more source

Philadelphia chromosome-positive B-cell acute lymphoblastic leukemia with e13a3 fusion transcripts in a patient with pre-existing essential thrombocythemia: a case report and literature review. [PDF]

Front Oncol
Wu Y, Cao D.
europepmc   +1 more source

Treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia in Jehovah's witness patients. [PDF]

Leuk Res Rep
Baron J, Pandey MR, Griffiths EA, Wang ES.   +3 more
europepmc   +1 more source

Sensitivity to Tyrosine Kinase Inhibitors in a Human Philadelphia Chromosome-Positive (Ph+) Leukemia Model With the T315I-Inclusive Compound Mutation. [PDF]

Cureus
Nguyen TT, Tamai M, Harama D, Kagami K, Komatsu C, Kasai S, Akahane K, Goi K, Inukai T.   +8 more
europepmc   +1 more source

Luskin MR, Murakami MA, Keating J, et al. Asciminib plus dasatinib and prednisone for Philadelphia chromosome-positive acute leukemia. Blood. 2025;145(6):577-589.

Blood
europepmc   +1 more source